Literature DB >> 346272

Gas chromatographic measurement of plasma levels of sodium valproate: tentative therapeutic range of a new anticonvulsant in the treatment of refractory epileptics.

F J Vajda, O H Drummer, P M Morris, J J McNeil, P F Bladin.   

Abstract

1. A precise and rapid gas chromatographic method for the measurement of plasma sodium valproate concentrations is presented. 2. The extraction is a single step procedure, and is reproducible and linear throughout the concentration range encountered. 3. Clinical evaluation of the drug is presented in eighteen epileptics on the basis of the percentage of days on which subjects had seizures before and after sodium valproate therapy. 4. A tentative therapeutic range for sodium valproate is presented on the basis of plasma levels and therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 346272     DOI: 10.1111/j.1440-1681.1978.tb00653.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

Review 1.  Computational modeling of epilepsy for an experimental neurologist.

Authors:  Abbey B Holt; Theoden I Netoff
Journal:  Exp Neurol       Date:  2012-05-14       Impact factor: 5.330

2.  Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients.

Authors:  G W Mihaly; F J Vajda; J L Miles; W J Louis
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

3.  Pharmacokinetics of sodium valproate in epileptic patients: prediction of maintenance dosage by single-dose study.

Authors:  G J Schapel; R G Beran; C J Doecke; W J O'Reilly; P A Reece; R H Rischbieth; L N Sansom; P E Stanley
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

4.  Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats.

Authors:  S Kojima; M Nadai; K Kitaichi; L Wang; T Nabeshima; T Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

Review 5.  Pharmacokinetic optimisation of anticonvulsant therapy.

Authors:  A H Thomson; M J Brodie
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.